Betamethasone Topical Side Effects
Applies to betamethasone topical: topical application cream, topical application lotion, topical application ointment, topical application spray.
Other dosage forms:
Precautions
It is very important that your doctor check your progress at regular visits for any unwanted effects that may be caused by this medicine.
If your symptoms do not improve within 2 to 4 weeks, or if they become worse, check with your doctor.
Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you have more than one of these symptoms while you are using this medicine: blurred vision, dizziness or fainting, a fast, irregular, or pounding heartbeat, increased thirst or urination, irritability, or unusual tiredness or weakness.
Check with your doctor right away if blurred vision, difficulty with reading, or any other change in vision occurs during or after treatment. Your doctor may want your eyes be checked by an ophthalmologist (eye doctor).
Check with your doctor right away if you have a skin rash, blistering, burning, crusting, dryness, flaking of the skin, itching, scaling, severe redness, stinging, swelling, or irritation on the skin.
Do not use cosmetics or other skin care products on the treated areas.
Tell your doctor if you are using other medications, including prescription or over-the-counter medications, especially if you take corticosteroid medications by mouth or use other corticosteroid-containing products on your skin. .
Serious side effects
Along with its needed effects, betamethasone topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking betamethasone topical:
More common side effects
- burning or stinging
- itching at the application site
Less common side effects
- blistering, burning, crusting, dryness, or flaking of the skin
- cracking or tightening of the skin
- dry skin
- flushing or redness of the skin
- irritation
- itching, scaling, severe redness, soreness, or swelling of the skin
- thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (eg, between the fingers)
- unusually warm skin
Rare side effects
- blistering, peeling, or loosening of the skin
Incidence not known
Other side effects
Some side effects of betamethasone topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
- raised, dark red, or wart-like spots on the skin, especially when used on the face
Rare side effects
- burning, itching, and pain in hairy areas, or pus at the root of the hair
Incidence not known
- acne or pimples
- burning and itching of the skin with pinhead-sized red blisters
- increased hair growth on the forehead, back, arms, and legs
- lightening of normal skin color
- lightening of treated areas of dark skin
- reddish purple lines on the arms, face, legs, trunk, or groin
- softening of the skin
For healthcare professionals
Applies to betamethasone topical: topical cream, topical foam, topical gel, topical lotion, topical ointment, topical spray.
General adverse events
The most commonly reported side effects were pruritus, burning, itching, irritation.
Hypersensitivity
- Rare (less than 0.1%): Hypersensitivity
Endocrine
- Frequency not reported: Cushing's syndrome[Ref]
Dermatologic
- Common (1% to 10%): Pruritus
- Uncommon (0.1% to 1%): Folliculitis, skin infections (including bacterial, fungal and viral skin infections)
- Frequency not reported: Dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae, miliaria[Ref]
Local
- Uncommon (0.1% to 1%): Application site pain
- Frequency not reported: Burning, itching, irritation[Ref]
Ocular
- Rare (less than 0.1%): Eye disorder
- Postmarketing reports: cataracts, glaucoma, increased intraocular pressure, central serous chorioretinopathy[Ref]
Metabolic
- Frequency not reported: Hyperglycemia
Renal
- Frequency not reported: Glucosuria
Other
- Rare (less than 0.1%): Rebound effect
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Vtama
Vtama (tapinarof) is a steroid-free, once-daily cream used to treat plaque psoriasis and atopic ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Methylprednisolone
Methylprednisolone is used to treat conditions such as allergies, arthritis, lupus and ulcerative ...
Cetirizine
Cetirizine treats cold or allergy symptoms such as sneezing, itching, watery eyes, or runny nose ...
Montelukast
Montelukast is a daily oral medication used to prevent asthma attacks, exercise-induced ...
References
1. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C (1983) "Potential hazards of topical steroid therapy." Am J Dis Child, 137, p. 1130-1
2. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C (1982) "Cushing's syndrome after topical application of corticosteroids." Am J Dis Child, 136, p. 274-5
3. Reymann F, Kehlet H (1979) "Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate." Arch Dermatol, 115, p. 362-3
4. Cunliffe WJ, Burton JL, Holti G, Wright V (1975) "Hazards of steroid therapy in hepatic failure." Br J Dermatol, 93, p. 183-5
5. Walsh P, Aeling JL, Huff L, Weston WL (1993) "Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids." J Am Acad Dermatol, 29, p. 501-3
6. Stevens DJ (1988) "Cushing's syndrome due to the abuse of betamethasone nasal drops." J Laryngol Otol, 102, p. 219-21
7. Flynn MD, Beasley P, Tooke JE (1992) "Adrenal suppression with intranasal betamethasone drops." J Laryngol Otol, 106, p. 827-8
8. Salde L, Lassus A (1983) "Systemic side-effects of three topical steroids in diseased skin." Curr Med Res Opin, 8, p. 475-80
9. (2001) "Product Information. Diprolene (betamethasone topical)." Schering Corporation
10. Sneddon I (1972) "Perioral dermatitis." Br J Dermatol, 87, p. 430-4
11. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J, et al. (1992) "Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis." J Am Acad Dermatol, 26, p. 125-7
12. Barkey WF (1987) "Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)." J Am Acad Dermatol, 17, p. 518-9
13. Grice K (1966) "Tinea of the hand and forearm. Betamethasone valerate atrophy." Proc R Soc Med, 59, p. 254-5
14. Hellgren L (1976) "Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis." Ann Clin Res, 8, p. 317-9
15. Macdonald A (1971) "Topical corticosteroid preparations. Hazards and side-effects." Br J Clin Pract, 25, p. 421-5
16. Ellis CN, Katz HI, Rex IH Jr, Shavin JS, Van Scott EJ, VanderPloeg D (1989) "A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis." Clin Ther, 11, p. 768-74
17. Kitazawa Y (1976) "Increased intraocular pressure induced by corticosteroids." Am J Ophthalmol, 82, p. 492-5
18. Butcher JM, Austin M, McGalliard J, Bourke RD (1994) "Bilateral cataracts and glaucoma induced by long term use of steroid eye drops." BMJ, 309, p. 43
19. Eisenlohr JE (1983) "Glaucoma following the prolonged use of topical steroid medication to the eyelids." J Am Acad Dermatol, 8, p. 878-81
More about betamethasone topical
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Dosage information
- Patient tips
- During pregnancy
- Drug class: topical steroids
- Breastfeeding
- En español
Patient resources
- Betamethasone Topical drug information
- Betamethasone dipropionate (Advanced Reading)
- Betamethasone valerate (Advanced Reading)
Other brands
Diprolene, Diprosone, Valisone, Sernivo, ... +5 more
Professional resources
- Betamethasone, Betamethasone Benzoate, Betamethasone Dipropionate, Betamethasone Valerate (Topical) monograph
- Betamethasone (FDA)
- Betamethasone Cream (FDA)
- Betamethasone Cream Augmented (FDA)
- Betamethasone Dipropionate (FDA)
Other brands
Diprolene, Sernivo, Diprolene AF
Related treatment guides
Further information
Betamethasone topical side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.